5. In regulation 229(1) (exemption for supply by national health service bodies and local authorities)—
(a)in paragraph (1), after “Regulations 214(1)” insert “and (2)”;
(b)after paragraph (2), insert—
“(2A) In relation to a medicinal product that is for parenteral administration, condition A only applies if the person who has given the written directions is an appropriate practitioner in relation to that medicinal product.”;
(c)in paragraph (3)(f), after “is supplied” insert “, either an authorisation by the licensing authority on a temporary basis under regulation 174 or”; and
(d)after paragraph (3), insert—
“(4) The following cease to have effect on 1st April 2022—
(a)in paragraph (1), “and (2)”; and
(b)paragraph (2A).”.
Paragraph (1) of regulation 229 has been amended by S.I. 2013/235 and 2015/323. Paragraph (3)(f) is to be substituted by S.I. 2019/775 as amended by S.I. 2020/1488.